Evidence map›Paper›PMID 28285212›Full record

ArticleInternational journal of surgery case reports2017

Glycogen Rich Clear Cell Carcinoma (GRCC) of the breast may not have a poor prognosis.

Muna M Baslaim, Enaam M Junainah, Hadeel H Ahmad, Anmar F Semilan, Ahmed O Al-Ghamdi, Noora O Rahimuddin, Budoor A Salman

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of surgery case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Clinical Imaging of Glycogen-rich Clear Cell Carcinoma of the Breast: A Case Series with Literature Review.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2019
    Review
  4. Article
  5. 21Turkish journal of surgery · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Muna M BaslaimDepartment of Surgery, Breast Unit, King Fahd General Hospital, Jeddah, Saudi Arabia. Electronic address: munabaslaim@hotmail.com.
Enaam M JunainahBreast Pathology, Breast Unit, King Fahd General Hospital, Jeddah, Saudi Arabia.
Hadeel H AhmadDepartment of Surgery, Breast Unit, King Fahd General Hospital, Jeddah, Saudi Arabia.
Anmar F SemilanDepartment of Surgery, Breast Unit, King Fahd General Hospital, Jeddah, Saudi Arabia.
Ahmed O Al-GhamdiDepartment of Surgery, Breast Unit, King Fahd General Hospital, Jeddah, Saudi Arabia.
Noora O RahimuddinDepartment of Surgery, Breast Unit, King Fahd General Hospital, Jeddah, Saudi Arabia.
Budoor A SalmanSurgical Research Unit, Breast Unit, King Fahd General Hospital, Jeddah, Saudi Arabia.
King Fahad Hospital Jeddah · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionGlycogen Rich Clear Cell Carcinoma (GRCC) is a rare variant of breast carcinomas and believed to be linked with a poor prognosis. CASE SUMMARY: We are presenting a 60-year-old Saudi lady with a 2cm GRCC carcinoma associated with clear cell ductal carcinoma in situ (DCIS) and no axillary lymph node involvement. The tumor was Estrogen and Progesterone receptors (ER & PR) positive and HER 2-neu negative. She underwent mastectomy with sentinel lymph node biopsy followed by hormonal therapy. She is alive and free of disease for 35 months.

conclusionThe prognosis of GRCC may not be different from other types of invasive breast cancer.

Indexed as

Case reportGlycogen rich clear cell carcinomaRare breast carcinoma sub-types

Identifiers

PMID28285212
PMCPMC5350496
OpenAlexW2593830359

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.